The volume of interstitial fluid (ISF) in the human body is three times that of blood. Yet,
collecting diagnostically useful ISF is more challenging than collecting blood because the …

Abstract Point‐of‐care (POC) has the capacity to support low‐cost, accurate and real‐time
actionable diagnostic data. Microneedle sensors have received considerable attention as an …

Detection of biomarkers associated with wound conditions provides in‐depth healthcare
information and benefits wound healing treatment. The current aim of wound detection is to …

Continuous monitoring of clinically relevant biomarkers within the interstitial fluid (ISF) using
microneedle (MN)‐based assays, has the potential to transform healthcare. This study …

Continuous glucose meters (CGMs) have tremendously boosted diabetes care by
emancipating millions of diabetic patients' need for repeated self‐testing by pricking their …

Wearable devices are gaining popularity in the fields of health monitoring, diagnosis, and
drug delivery. Recent advances in wearable technology have enabled real-time analysis of …

Managing diabetes is a chronic challenge today, requiring monitoring and timely insulin
injections to maintain stable blood glucose levels. Traditional clinical testing relies on …

Interstitial fluid (ISF) has attracted extensive attention in an extremely wide range of areas
due to its unique advantages, such as portability, high precision, comfortable operation, and …

In vivo drug monitoring is crucial for evaluating the effectiveness and safety of drug
treatment. Blood sampling and analysis is the current gold standard but needs professional …

Background Regular blood glucose monitoring is very important for diabetic patients. The
composition of skin interstitial fluid (ISF) is similar to that of blood, which can be used for …